Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2026-01-07 @ 2:24 PM
Study NCT ID:
NCT02977468
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2016-11-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
Sponsor:
Eileen Connolly
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AAAQ7863
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |